NEOS Investment Management LLC Acquires 5,143 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

NEOS Investment Management LLC increased its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 523.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,125 shares of the biotechnology company’s stock after acquiring an additional 5,143 shares during the quarter. NEOS Investment Management LLC’s holdings in Axon Enterprise were worth $3,640,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of AXON. DRW Securities LLC acquired a new position in shares of Axon Enterprise during the third quarter valued at about $291,000. The Manufacturers Life Insurance Company raised its holdings in Axon Enterprise by 0.6% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 43,643 shares of the biotechnology company’s stock valued at $17,440,000 after acquiring an additional 276 shares in the last quarter. Dai ichi Life Insurance Company Ltd lifted its position in shares of Axon Enterprise by 63.6% in the 3rd quarter. Dai ichi Life Insurance Company Ltd now owns 3,646 shares of the biotechnology company’s stock worth $1,457,000 after acquiring an additional 1,418 shares during the period. D.A. Davidson & CO. grew its holdings in shares of Axon Enterprise by 0.3% during the 3rd quarter. D.A. Davidson & CO. now owns 12,622 shares of the biotechnology company’s stock worth $5,044,000 after purchasing an additional 44 shares in the last quarter. Finally, Quantbot Technologies LP bought a new stake in shares of Axon Enterprise during the third quarter valued at approximately $84,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Trading Down 1.5 %

Shares of AXON opened at $550.65 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a market cap of $42.19 billion, a price-to-earnings ratio of 142.29, a PEG ratio of 5.17 and a beta of 1.12. The stock has a fifty day moving average price of $590.80 and a two-hundred day moving average price of $546.79. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99.

Analyst Ratings Changes

Several research analysts recently commented on AXON shares. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a research report on Monday, March 10th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. TD Cowen started coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 target price on the stock. Robert W. Baird raised their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Finally, The Goldman Sachs Group upped their price objective on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $604.67.

Insider Activity

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Jeri Williams sold 307 shares of the business’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares of the company’s stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.